StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kiora Pharmaceuticals's price to book ratio was 0.4× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 14.6×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×+0.1
2025Dec 31, 20250.3×−0.0
2024Dec 31, 20240.3×−0.2
2023Dec 29, 20230.5×−13.6
2022Dec 30, 202214.1×+13.2
2021Dec 31, 20210.9×−2.8
2020Dec 31, 20203.7×−2.0
2019Dec 31, 20195.7×−20.9
2018Dec 31, 201826.6×−369.8
2017Dec 29, 2017396.5×+326.0
2016Dec 30, 201670.5×+35.1
2015Dec 31, 201535.4×–

More Kiora Pharmaceuticals figures

See a number that looks wrong?